# Immucell Corp: Form 8-K, filed Sep 24, 2024

- Company: [Immucell Corp](/companies/iccc.md) (CIK 811641)
- Form: 8-K
- Filed: 2024-09-24
- Accepted by EDGAR: Sep 24, 2024, 15:55 ET
- Period: 2024-09-20
- Accession: 0001213900-24-081304
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/811641/000121390024081304/ea0215492-8k_immucell.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/811641/000121390024081304/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/811641/000121390024081304/ea0215492-8k_immucell.htm

Filed Sep 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-081304. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.